Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Majuven is an early and growth stage venture capital firm founded in 2011/2012 by experienced business leaders in Singapore. The firm focuses on high-growth science and technology-intensive private businesses across Asia. Co-founded by Lee Hsien Yang, Majuven leverages its extensive network to support portfolio companies in their regionalization efforts, particularly in disruptive trends in healthcare, financial services, and digital consumerism.
As of now, Majuven manages a fund size of $50 million and primarily invests in companies at the Seed to Series B stages. The firm has established a reputation for backing technology leaders who are creating lasting impacts in their respective sectors. Majuven's founding team includes notable figures who enhance its strategic guidance capabilities. The firm is headquartered in Singapore, positioning it well within the Asian market.
Majuven invests in high-tech sectors, specifically targeting healthcare, fintech, commerce, artificial intelligence, and climate technologies. The firm focuses on companies at the Seed to Series B stages that are beginning to implement clear monetization strategies. Majuven's investment strategy emphasizes assisting these companies in navigating the complexities of regionalization across Asia, utilizing its vast network to facilitate growth.
The firm’s thesis revolves around three key sectors driven by evolving trends in technology, demography, and affluence: Biomedical Sciences / Healthcare, Digital Convergence in Technology and Services (including fintech and digital consumerism), and Sustainable Technologies / Clean Technology. Majuven typically invests between $10 million to $50 million per deal, with a deal pace of 2 to 6 investments per year, targeting companies that are approximately 4 to 5 years old at the time of investment.
Majuven's portfolio includes notable companies that reflect its focus on high-tech sectors:
These companies exemplify Majuven's commitment to investing in innovative solutions within the healthcare and technology sectors, showcasing the firm's ability to identify and support high-growth potential businesses.
Lee Hsien Yang - Co-Founder. Lee is the son of Singapore's founding Prime Minister, Lee Kuan Yew, and has a strong background in business leadership. He is currently based in the UK after being granted political asylum in 2024.
Lim Ho Kee - Founding & Managing Partner. Lim has extensive experience in venture capital and has been instrumental in shaping Majuven's investment strategy.
Prof. Low Teck Seng - Founding Partner. Prof. Low brings academic expertise and a strong network in the biomedical sciences sector, enhancing Majuven's focus on healthcare investments.
Lu Yoh Chie - Founding Partner. Lu has a background in technology and finance, contributing to Majuven's investment in fintech and digital consumerism.
To pitch Majuven, startups should use the preferred channel available on their website at majuven.com. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. Majuven typically responds within a few weeks, and warm introductions are encouraged to enhance the chances of securing a meeting.
In March 2020, Majuven sought to raise up to $50 million for its second fund, indicating a continued commitment to investing in high-growth sectors across Asia. The firm has been active in the healthcare and fintech spaces, with notable investments in companies like Eureka Therapeutics, which raised $21 million in a Series C round in 2014.
Recent reports highlight Majuven's focus on supporting startups that are navigating the complexities of regionalization in Asia, leveraging its extensive network to facilitate growth. The firm continues to explore opportunities in the digital consumerism sector, particularly through investments in platforms like 17 Media (17LIVE).
What are Majuven's investment criteria?
Majuven primarily invests in high-tech sectors, focusing on healthcare, fintech, commerce, AI, and climate technologies. The firm targets companies at the Seed to Series B stages that are beginning to implement clear monetization strategies.
How can startups apply or pitch to Majuven?
Startups can pitch to Majuven through their website at majuven.com. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Majuven different from other venture capital firms?
Majuven distinguishes itself through its extensive network across Asia, which it leverages to assist portfolio companies in their regionalization efforts. The firm also has a strong focus on high-growth science and technology-intensive businesses.
What is Majuven's geographic scope?
The firm primarily focuses on investments within Asia but is open to global opportunities that align with its investment thesis.
What is Majuven's typical check size?
Majuven typically invests between $10 million to $50 million per deal, depending on the stage and potential of the company.
What kind of post-investment involvement does Majuven have?
Majuven provides strategic guidance and access to its extensive network, which is essential for the regionalization of its portfolio companies. The firm actively supports its companies in navigating market complexities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.